Bio Place

Latest Medical, Biological, and Genomic News!


icon

FDA approves mAb against amyloid plaque for Alzheimers

"Although Leqembi is not a cure for Alzheimer’s, a large clinical trial...showed the treatment slowed the cognitive and functional decline of patients with early-stage Alzheimer’s by 27% relative to placebo."
STAT
2023-01-07 06:35:37